The Omsk State Medical University is a school of medicine in Omsk, Russia.

During the past decade, Omsk State Medical Academy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Omsk State Medical Academy" are "Ulcerative Colitis" (2 trials), "Colitis, Ulcerative" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Omsk State Medical Academy" in a lesser frequency.

Most popular intervention types in "Omsk State Medical Academy" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Mesalamine" (2 trials), "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials) and "Vedolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Omsk State Medical Academy" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Omsk State Medical Academy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Omsk State Medical Academy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Omsk State Medical Academy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".